Revance Therapeutics Inc. buy BiotechBee
Start price
03.01.23
/
70%
€17.50
Target price
31.12.25
€30.00
Performance (%)
76.00%
End price
05.05.23
€30.80
Summary
This prediction ended on 05.05.23 with a price of €30.80. With a performance of 76.00% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1.111% | 0.196% | 1.211% | 51.832% |
| iShares Nasdaq 100 | -4.346% | -3.249% | 25.873% | 80.642% |
| iShares Nikkei 225® | -6.785% | -7.717% | 50.968% | 69.238% |
| iShares S&P 500 | -1.788% | 0.993% | 21.073% | 67.424% |
According to BiotechBee what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year